Literature DB >> 24398066

Neither too much, nor too little. The dilemma of identifying personality disorders in adolescents patients with self-reports.

Ernesto Magallón-Neri1, José Eugenio De la Fuente2, Gloria Canalda2, Maria Forns3, Raquel García2, Esther González2, Anais Lara2, Josefina Castro-Fornieles4.   

Abstract

The study aimed to compare methods of identification of Personality Disorders (PD) in adolescent patients with psychiatric disorders. A sample of 120 Spanish adolescents with clinical disorders was assessed using the International Personality Disorder Examination (IPDE) interview, its Screening Questionnaires (IPDE-SQ) comprising the ICD-10 and DSM-IV modules, and also the Temperament Character Inventory (TCI) to identify risk of PD. The IPDE-SQ identified a risk of PD around 92-97% of the sample; 61.7% when adjusting the stricter cut-off points. The TCI showed a PD risk of 20%, whereas the prevalence of PD identified by the IPDE clinical interview was around 36-38%. The differences between the IPDE, IPDE-SQ and TCI were significant, and a low agreement among instruments was obtained. Large discrepancy between self-report instruments in identifying PD with regard to the clinical interview raises several questions concerning the use of these instruments in clinical settings on adolescents with psychiatric disorders.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adolescents; Concordance (measurement); Personality; Personality disorders; Self-report

Mesh:

Year:  2013        PMID: 24398066     DOI: 10.1016/j.psychres.2013.12.020

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  1 in total

1.  Personality psychopathology, drug use and psychological symptoms in adolescents with substance use disorders and community controls.

Authors:  Ernesto Magallón-Neri; Rosa Díaz; Maria Forns; Javier Goti; Josefina Castro-Fornieles
Journal:  PeerJ       Date:  2015-06-09       Impact factor: 2.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.